# Zoltan Laszlo, M.D. – FDA Inspection, May 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/zoltan-laszlo-md/fd2fce34-066e-43db-abfd-6aa4dd2215fa
Source feed: FDA_Inspections

> FDA inspection 1053472 of Zoltan Laszlo, M.D., May 18, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053472
- Company Name: Zoltan Laszlo, M.D.
- Inspection Date: 2018-05-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrace-deyampert/cdb4f833-488b-42b9-abab-4216435bce4c)

Company: https://www.keypedia.com/companies/zoltan-laszlo-md/b94ed2b4-3d41-4745-acc3-03146dcadf2c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c